Inspire Veterinary Partners Files 8-K
Ticker: IVPR · Form: 8-K · Filed: Aug 20, 2025 · CIK: 1939365
| Field | Detail |
|---|---|
| Company | Inspire Veterinary Partners, Inc. (IVPR) |
| Form Type | 8-K |
| Filed Date | Aug 20, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $1,562,005, $10 m, $5 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, other-events
TL;DR
Inspire Vet Partners filed an 8-K, something happened.
AI Summary
Inspire Veterinary Partners, Inc. filed an 8-K on August 20, 2025, to report other events. The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself.
Why It Matters
This 8-K filing indicates a material event has occurred for Inspire Veterinary Partners, Inc., requiring disclosure to investors.
Risk Assessment
Risk Level: medium — The lack of specific details in the 8-K filing creates uncertainty about the nature and impact of the reported event.
Key Players & Entities
- INSPIRE VETERINARY PARTNERS, INC. (company) — Registrant
- August 20, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 001-41792 (identifier) — Commission File Number
- 85-4359258 (identifier) — I.R.S. Employer Identification No.
- 780 Lynnhaven Parkway , Suite 400 Virginia Beach , VA 23452 (address) — Address of principal executive offices
- ( 757 ) 734-5464 (phone_number) — Registrant's telephone number
FAQ
What specific event is Inspire Veterinary Partners, Inc. reporting in this 8-K filing?
The filing is categorized under 'Other Events' but does not provide specific details regarding the nature of the event.
When was the earliest event reported in this filing?
The earliest event reported was on August 20, 2025.
What is the state of incorporation for Inspire Veterinary Partners, Inc.?
The company is incorporated in Nevada.
What is the principal executive office address for the company?
The principal executive offices are located at 780 Lynnhaven Parkway, Suite 400, Virginia Beach, VA 23452.
What is the registrant's telephone number?
The registrant's telephone number is (757) 734-5464.
Filing Stats: 656 words · 3 min read · ~2 pages · Grade level 12.9 · Accepted 2025-08-20 15:40:56
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 IVP Nasdaq Capital Market Indicat
- $1,562,005 — n the Company's stockholders' equity of $1,562,005, as reported in the Company's Annual Re
- $10 m — The aggregate offering amount is up to $10 million, to be completed in one or more c
- $5 million — for aggregate proceeds of approximately $5 million. Proceeds were received in cash and thr
Filing Documents
- ea0254004-8k_inspire.htm (8-K) — 26KB
- 0001213900-25-078952.txt ( ) — 190KB
- ivp-20250820.xsd (EX-101.SCH) — 3KB
- ivp-20250820_lab.xml (EX-101.LAB) — 33KB
- ivp-20250820_pre.xml (EX-101.PRE) — 22KB
- ea0254004-8k_inspire_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. As previously disclosed, on April 10, 2025, Inspire Veterinary Partners, (the "Company") received a notice letter (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, based on the Company's stockholders' equity of $1,562,005, as reported in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, the Company is no longer in compliance with the minimum stockholders' equity requirement for continued inclusion on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1) (the "Stockholders' Equity Requirement"). The Company had 45 calendar days from the date of the Notice to submit its plan to regain compliance to Nasdaq, which was submitted on May 23, 2025. Also, as previously disclosed, on July 28, 2025, the Company entered into a Securities Purchase Agreement with certain accredited investors for of up to 7,590 shares of Series B convertible preferred stock ("Series B Preferred Stock") and accompanying warrants ("Warrants") to purchase shares of the Company's common stock (the "Private Placement"). The aggregate offering amount is up to $10 million, to be completed in one or more closings. On July 29, 2025, the Company completed the first closing of the Private Placement, issuing 6,340 shares of Series B Preferred Stock and 6,340,000 Warrants for aggregate proceeds of approximately $5 million. Proceeds were received in cash and through the transfer of certain securities in lieu of cash. As of the date of this Report on Form 8-K, the Company believes, as a result of the first closing of the Private Placement, it has regained compliance with the Stockholders' Equity Requirement. Nasdaq will continue to monitor the Company's ongoing compliance with the stockholders' equity requirement and, if at the time of its next periodic report the Company does not evidence compliance, it may be subject to delisting. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 20, 2025 INSPIRE VETERINARY PARTNERS, INC. By: /s/ Kimball Carr Name: Kimball Carr Title: President and Chief Executive Officer 2